JSC
DXCM icon

Jackson Square Capital’s DexCom DXCM Stock Holding History

Jackson Square Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,600
Closed -$1K – 202
2020
Q3 		$1K Buy
1,600
+800
+100% +$83.6K ﹤0.01% 335
2020
Q2 		$2K Buy
+800
New +$71.6K ﹤0.01% 305

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jackson Square Capital's DXCM Position: Q4 2023 in Review

Jackson Square Capital sold out of DexCom (DXCM) in Q4 2023, closing a stake of 5,737 shares — an estimated $535K sold.

Jackson Square Capital first reported a position in DXCM in Q4 2019 and held it in 16 quarters. The position peaked at $4.93M in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Jackson Square Capital reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Jackson Square Capital sold 5,737 DexCom shares in Q4 2023, an estimated $535K.
  • Jackson Square Capital first reported a position in DexCom in Q4 2019 and held it in 16 quarters.
  • Jackson Square Capital's DexCom position peaked at $4.93M in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Jackson Square Capital's 13F filing for Q4 2023, filed 9 Jan 2024.